Acorda Therapeutics

$8.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:40 PM UTC today

Why Robinhood?

You can buy or sell ACOR and other stocks, options, and ETFs commission-free!

About ACOR

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, and GGF2 (Cimaglermin alfa). The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY. The listed name for ACOR is Acorda Therapeutics, Inc. Common Stock.

CEO
Ronald Cohen
Employees
344
Headquarters
Ardsley, New York
Founded
1995
Market Cap
63.45M
Price-Earnings Ratio
1.43
Dividend Yield
—
Average Volume
4.70M
High Today
$8.25
Low Today
$7.95
Open Price
$8.25
Volume
68.40K
52 Week High
$15.30
52 Week Low
$2.53

Collections

ACOR Earnings

-$1.06
-$0.71
-$0.35
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 11, After Hours

You May Also Like

RALS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure